A Phase II Randomized, Placebo-Controlled Study to Evaluate the Safety, Tolerability,and Efficacy of Different Regimens of MK-7009 When Administered Concomitantly with Pegylated Interferon and Ribavirin in Treatment-Naïve Patients with Chronic Genotype 1